Clinical Trials Browser

Phase EARLY_PHASE1 × Glioblastoma × defactinib × Clear all

NCT05798507 2025-12-15

Identification of Treatment Concentrations of Defactinib or VS-6766 for the Treatment of Patients With Glioblastoma

Phase EARLY_PHASE1 Active not recruiting

Glioblastoma